Latest Non Dilutive Funding News

Latitude 66 has agreed to sell its 17.5% interest in the Greater Duchess Joint Venture for an upfront A$2 million, with potential for further contingent payments, while progressing exploration in Australia and Finland amid regulatory challenges.

European Metals Holdings has received a $36 million EU grant to support its Cinovec Lithium Project in the Czech Republic, while progressing its Definitive Feasibility Study and environmental permitting.

Caravel Minerals has secured a $15 million non-dilutive loan facility to fund the Definitive Feasibility Study for its Caravel Copper Project, alongside finalising a simplified process flowsheet and initiating key engineering tenders.

Vital Metals’ latest Scoping Study for its Tardiff deposit in Canada reveals strong economic potential, underpinning an 11-year mine life with significant rare earth and niobium production. The company plans to advance to a Prefeasibility Study by the end of 2026, aiming to optimize recoveries and expand resources.

Neurizon Therapeutics has made significant strides in developing its lead ALS drug candidate NUZ-001, unveiling a new liquid formulation and submitting a key regulatory response to the FDA. Clinical and preclinical data bolster hopes for broader neurodegenerative applications.

Neurizon Therapeutics has secured a $1.5 million loan against its expected 2025 R&D tax rebate, boosting liquidity without diluting shareholders. This strategic move supports ongoing development of its neurodegenerative disease treatments.

Actinogen Medical has reached a key milestone in its XanaMIA phase 2b/3 Alzheimer’s trial with over 100 participants enrolled, setting the stage for an interim analysis in January 2026. The company also secured a $13.8 million non-dilutive R&D funding facility to support ongoing development.

Noxopharm has initiated its HERACLES clinical trial for SOF-SKN, marking a key milestone for its Sofra platform, while deepening partnerships and actively seeking new funding to sustain development.

EMVision Medical Devices reports strong progress in its pivotal trial for the emu™ bedside brain scanner and successful aeromedical testing of its First Responder device, backed by a $5 million government grant and $10.5 million in cash reserves.

International Graphite Limited has partnered with Arctic Graphite AS to establish a new expandable graphite facility in Germany, aiming to bolster European supply with an initial 3,000 tonnes per year capacity. Backed by a potential $10 million funding commitment, this venture marks a strategic push into critical mineral processing amid rising demand.

Winsome Resources progresses key permitting and exploration milestones at its Adina Lithium Project while maintaining a strong cash position and deferring the Renard Option decision amid subdued lithium market conditions.

Thor Energy has agreed to sell a majority stake in its US uranium projects to Metals One, securing upfront cash and stock consideration while focusing on its hydrogen and helium ambitions.